Mohamad Mroué

4PUBLICATIONS
8CO-AUTHORS
Molecular medicineCancer therapy (excl. chemotherapy and radiation therapy)Proteins and peptides
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Feb 24, 2024
Netazepide, an Antagonist of Cholecystokinin Type 2 Receptor, Prevents Vincristine-Induced Sensory Neuropathy in Mice.

Amandine Bernard, Mohamad Mroué, Sylvie Bourthoumieu

|Jan 26, 2024
Neuroprotective Effect of Polyvalent Immunoglobulins on Mouse Models of Chemotherapy-Induced Peripheral Neuropathy.

Mohamad Mroué, Flavien Bessaguet, Angélique Nizou

|Dec 23, 2022
Blockade of Cholecystokinin Type 2 Receptors Prevents the Onset of Vincristine-Induced Neuropathy in Mice.

Amandine Bernard, Aurore Danigo, Mohamad Mroué

|Nov 27, 2021
The Cholecystokinin Type 2 Receptor, a Pharmacological Target for Pain Management.

Amandine Bernard, Aurore Danigo, Sylvie Bourthoumieu

Pageof 1